Concepedia

Avery Polk

AP

6

Publications

388

Citations

6

H-Index

2014

Active since

Affiliations

University of Michigan(Current)

University of Pittsburgh

Avery Polk is an author at University of Michigan specializing in tumor immunity, immunology, and immune regulation.

ORCID

Top concepts

Publications per year

2014–2019

6

Publications

6

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Tianjiao Wang, Andrew L. Feldman, David A. Wada et al. · Blood · 2014 · 179 citations · Full text

Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability

Carlos Murga‐Zamalloa, Delphine Rolland, Avery Polk et al. · Clinical Cancer Research · 2019 · 65 citations · Full text

T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy

Tianjiao Wang, Ye Lu, Avery Polk et al. · Clinical Cancer Research · 2016 · 56 citations · Full text

Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia

Avery Polk, Ye Lu, Tianjiao Wang et al. · Clinical Cancer Research · 2016 · 42 citations · Full text

A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T‐cell lymphomas

Philip S. Boonstra, Avery Polk, Noah A. Brown et al. · American Journal of Hematology · 2017 · 27 citations · Full text

, , +19

Rows per page

1–5 of 6